Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting.
Barclay S, Pol S, Mutimer D, Benhamou Y, Mills PR, Hayes PC, Cameron S, Carman W. Barclay S, et al. J Clin Virol. 2008 Apr;41(4):243-54. doi: 10.1016/j.jcv.2007.11.017. Epub 2008 Jan 18. J Clin Virol. 2008. Corrected and republished in: J Clin Virol. 2008 May;42(1):104-15. doi: 10.1016/j.jcv.2008.03.021 PMID: 18203658 Corrected and republished. No abstract available.
Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness.
Innes HA, Hutchinson SJ, Barclay S, Cadzow E, Dillon JF, Fraser A, Goldberg DJ, Mills PR, McDonald SA, Morris J, Stanley A, Hayes P; Hepatitis C Clinical Database Monitoring Committee. Innes HA, et al. Among authors: barclay s. Hepatology. 2013 Feb;57(2):451-60. doi: 10.1002/hep.26051. Epub 2013 Jan 8. Hepatology. 2013. PMID: 22961861
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?
McDonald SA, Innes HA, Hayes PC, Dillon JF, Mills PR, Goldberg DJ, Barclay S, Allen S, Fox R, Fraser A, Kennedy N, Bhattacharyya D, Hutchinson SJ. McDonald SA, et al. Among authors: barclay s. J Hepatol. 2015 Feb;62(2):262-8. doi: 10.1016/j.jhep.2014.08.046. Epub 2014 Sep 6. J Hepatol. 2015. PMID: 25195556
Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.
Innes HA, McDonald SA, Dillon JF, Allen S, Hayes PC, Goldberg D, Mills PR, Barclay ST, Wilks D, Valerio H, Fox R, Bhattacharyya D, Kennedy N, Morris J, Fraser A, Stanley AJ, Bramley P, Hutchinson SJ. Innes HA, et al. Among authors: barclay st. Hepatology. 2015 Aug;62(2):355-64. doi: 10.1002/hep.27766. Epub 2015 Mar 25. Hepatology. 2015. PMID: 25716707
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection.
Valerio H, Goldberg DJ, Lewsey J, Weir A, Allen S, Aspinall EJ, Barclay ST, Bramley P, Dillon JF, Fox R, Fraser A, Hayes PC, Innes H, Kennedy N, Mills PR, Stanley AJ, Hutchinson SJ. Valerio H, et al. Among authors: barclay st. Drug Alcohol Depend. 2015 Sep 1;154:125-31. doi: 10.1016/j.drugalcdep.2015.06.032. Epub 2015 Jul 2. Drug Alcohol Depend. 2015. PMID: 26183402
The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort.
Wang H, Innes H, Hutchinson SJ, Goldberg DJ, Allen S, Barclay ST, Bramley P, Fox R, Fraser A, Hayes PC, Kennedy N, Mills PR, Dillon JF. Wang H, et al. Among authors: barclay st. Eur J Gastroenterol Hepatol. 2016 Apr;28(4):398-404. doi: 10.1097/MEG.0000000000000556. Eur J Gastroenterol Hepatol. 2016. PMID: 26695428
474 results